404 related articles for article (PubMed ID: 26645392)
1. Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.
Kappos L; Radue EW; Chin P; Ritter S; Tomic D; Lublin F
J Neurol; 2016 Feb; 263(2):354-360. PubMed ID: 26645392
[TBL] [Abstract][Full Text] [Related]
2. Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients.
De Stefano N; Tomic D; Radue EW; Sprenger T; Meier DP; Häring D; Sormani MP
Mult Scler Relat Disord; 2016 May; 7():98-101. PubMed ID: 27237768
[TBL] [Abstract][Full Text] [Related]
<
